Magda Michna
Vermögen: 1 Mio $ am 31.05.2026
Vermögen: 1 Mio $ am 31.05.2026
Magda Michna is currently Chief Development Officer at STAAR Surgical Co., starting in 2025.
Formerly, Dr. Michna was Head-Chief Global Clinical & Medical Officer at AcuFocus, Inc. from 2018 to 2023 and Chief Clinical Officer at Presbia PLC from 2012 to 2017.
Education includes undergraduate and doctorate degrees from the University of Melbourne.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
STAAR SURGICAL COMPANY 0,09 % | 15.05.2026 | 42 783 ( 0,09 % ) | 1 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| STAAR SURGICAL COMPANY | Corporate Officer/Principal | 18.03.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
AcuFocus, Inc.
AcuFocus, Inc. Medical SpecialtiesHealth Technology Manufactures and wholesales ophthalmic medical device | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2023 |
| PRESBIA PLC | Technik-/Wissenschafts-/F&E-Leiter | 02.01.2017 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
STAAR Surgical Co.
STAAR Surgical Co. Medical SpecialtiesHealth Technology Designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver lenses into the eye | Health Technology |
AcuFocus, Inc.
AcuFocus, Inc. Medical SpecialtiesHealth Technology Manufactures and wholesales ophthalmic medical device | Health Technology |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Presbia PLC
Presbia PLC Medical SpecialtiesHealth Technology Develops, manufactures and commercializes Presbia Flexivue Microlens | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen